Walmart(US:WMT) Zhi Tong Cai Jing·2026-01-10 05:49Group 1 - Walmart will join the Nasdaq-100 Index, replacing AstraZeneca, effective January 20, following its transfer from the New York Stock Exchange to Nasdaq, which was the largest exchange switch in history [1] - Analysts from Jefferies estimated that Walmart's inclusion could lead to nearly $19 billion in passive fund inflows due to adjustments in index-tracking funds and exchange-traded products [1] - Walmart's market capitalization has risen to nearly $1 trillion, driven by strong sales growth and market share gains as consumers increasingly prefer low-cost essentials [1] Group 2 - Over the past three years, Walmart's stock price has increased by 146%, while AstraZeneca's stock price has risen by 42% during the same period [2] - AstraZeneca's removal from the index reflects a continued decline since its peak during the pandemic, when its COVID-19 vaccine boosted its inclusion in the index [2] - As of December 2025, assets tracking the Nasdaq-100 Index through ETFs are expected to exceed $600 billion, including $408 billion in the Invesco QQQ Trust series [2]